Elon Musk’s latest maneuver in his ever-expanding empire—allocating 25% equity in his artificial intelligence startup, xAI, to the investors who backed his $44 billion Twitter acquisition—has raised questions about the nature of the transaction.
Musk acquired Twitter in late 2022 with significant financial backing from major investors, including Fidelity, Sequoia Capital, Andreessen Horowitz, Oracle co-founder Larry Ellison, and Saudi Arabia’s Prince Alwaleed bin Talal. The deal heavily relied on equity financing, with Musk raising $7.1 billion from these investors and supplementing the purchase with $13 billion in debt from banks like Morgan Stanley and Barclays.
However, since the acquisition, Twitter—now renamed X—has struggled. A mass exodus of advertisers and concerns about content moderation have driven the platform’s valuation down. Fidelity, which publicly discloses its stake, recently slashed its valuation of X to $9.4 billion, marking an almost 80% drop from the purchase price.
Against this backdrop, Musk’s AI company, xAI, has thrived. Founded in 2023, the startup has rapidly grown, with its valuation doubling to $50 billion following a $5 billion fundraising round that is expected to close soon. This rise has provided an unexpected boost for Twitter investors, who Musk announced in 2023 would own 25% of xAI.
25% of xAI: Reinvestment or Compensation?
Musk himself hinted at the deal in a post on X in November 2023, stating, “X investors will own 25% of xAI.” However, he provided no further details, leaving observers to wonder whether this stake was a direct equity gift or tied to participation in fundraising rounds.
The Financial Times recently reported that “people with knowledge of the matter” said the 25% allocation occurred “across both fundraising rounds” and that X investors’ stakes were not diluted by new shares issued during xAI’s latest funding round. This exclusivity indicates that the investors were offered privileged access to xAI, but whether that access required additional financial contributions has not been explicitly confirmed.
The narrative has raised two primary interpretations. One is that Musk compensated Twitter investors for their losses by transferring xAI equity outright—a way to reward loyalty during a tumultuous time for X. The other is that investors secured their stakes by committing additional funds during xAI’s funding rounds, aligning their interests with Musk’s broader business ventures.
E.W. Niedermeyer, a journalist and commentator, quoted Financial Times saying, “People with knowledge of the matter said X investors had been granted a quarter of the equity in xAI across both fundraising rounds. Their stake was not diluted by the new shares issued following the close of the latest fundraise, they added.”
Keubiko, a widely followed tech analyst, questioned the framing of the arrangement, asking, “Is this actually true as the FT is reporting? My understanding is X investors have simply been offered the ‘opportunity’ to invest.”
Allocation
While details remain unclear, the arrangement appears to reward X investors who continued to back Musk’s ventures during xAI’s May 2024 $6 billion raise and the current $5 billion round. Musk’s decision to link the fortunes of X and xAI underscores his strategy of creating interconnected ecosystems of investors who benefit across his businesses, from Tesla to SpaceX.
By restricting participation in xAI’s latest funding round to previous investors, Musk ensured that only those already loyal to him would profit from the AI company’s growth. This exclusivity has been a hallmark of Musk’s approach, where loyalty and reinvestment are key.
The lack of transparency surrounding the deal raises questions about governance and potential conflicts of interest. While Musk’s ability to create value across his companies is undeniable, the overlapping incentives and intertwined financing arrangements could complicate investor relations and corporate oversight.
Information for this briefing was found via Financial Times and the sources mentioned. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.
